Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: August 9, 2019
Drug shortages have the potential to diminish health outcomes; therefore, it is important for dermatologists to be aware of current shortages impac...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: November 26, 2018
Patient’s fears regarding rare potential adverse events can lead to poor adherence and treatment refusal, even for the most efficacious treatments....
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: November 26, 2018
Targeted campaigns have been largely unsuccessful in discouraging minors from tanning. New approaches to combating adolescent tanning injuries may ...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: October 30, 2018
Psoriasis is a chronic inflammatory disease with both a physical and psychosocial burden. To offer strategies for dermatology residents to assess a...
Audio
- Author:
- Steven R. Feldman, MD, PhD
Publish date: September 5, 2018
In this episode of the “Peer to Peer” podcast series with Dr. Vincent DeLeo, Dr. Steven Feldman discusses results from a recent study he and his co...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: August 30, 2018
Although topical corticosteroids are the mainstay of treatment of atopic dermatitis (AD), these medications may lose efficacy over time, a phenomen...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: July 9, 2018
Rosacea patients often are burdened with embarrassment, social anxiety, and psychiatric comorbidities. The Patient Health Questionnaire 9 (PHQ-9) i...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: February 3, 2017
Growing incentives to control health care costs may cause accountable care organizations (ACOs) to reconsider how skin disease is best managed...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: October 3, 2016
Educating patients about the risks of treatment is obligatory. An inherent problem with risk education is that patients can become terrified of rar...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: September 1, 2016
The US Food and Drug Administration uses the term boxed warning to highlight potentially dangerous situations associated with prescription drugs. A...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: December 14, 2015
Atopic dermatitis (AD) is one of the most commonly diagnosed dermatologic conditions in the United States. Topical agents are the mainstay of treat...
Audio
- Author:
- Steven R. Feldman, MD, PhD
Publish date: August 24, 2015
Adherence to psoriasis therapies, especially topical therapy, is remarkably poor. Dr. Steven Feldman discusses the patient-physician relationship a...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: December 10, 2014
The dermatologic conditions that are most commonly encountered by nondermatologists are not well characterized, which can hamper efforts to train t...
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: November 1, 2013
Psoriasis can have a large impact on a patient’s quality of life, yet adherence to psoriasis treatment often is poor.
Article
- Author:
- Steven R. Feldman, MD, PhD
Publish date: February 24, 2013
